Home > National Drug Code (NDC) > Neutrogena Clinical Lifting Wrinkle Treatment System

Neutrogena Clinical Lifting Wrinkle Treatment System - 10812-173-90 - (Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone)

Alphabetical Index


Drug Information of Neutrogena Clinical Lifting Wrinkle Treatment System

Product NDC: 10812-173
Proprietary Name: Neutrogena Clinical Lifting Wrinkle Treatment System
Non Proprietary Name: Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone
Active Ingredient(s): 30; 120; 50; 50; 30    mg/mL; mg/mL; mg/mL; mg/mL; mg/mL & nbsp;   Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone
Administration Route(s): TOPICAL
Dosage Form(s): CREAM
Coding System: National Drug Codes(NDC)

Labeler Information of Neutrogena Clinical Lifting Wrinkle Treatment System

Product NDC: 10812-173
Labeler Name: Neutrogena Corporation
Product Type: HUMAN OTC DRUG
FDA Application Number: part352
Marketing Category: OTC MONOGRAPH FINAL
Start Marketing Date: 20100415

Package Information of Neutrogena Clinical Lifting Wrinkle Treatment System

Package NDC: 10812-173-90
Package Description: 1 BOTTLE, PUMP in 1 KIT (10812-173-90) > 10 mL in 1 BOTTLE, PUMP

NDC Information of Neutrogena Clinical Lifting Wrinkle Treatment System

NDC Code 10812-173-90
Proprietary Name Neutrogena Clinical Lifting Wrinkle Treatment System
Package Description 1 BOTTLE, PUMP in 1 KIT (10812-173-90) > 10 mL in 1 BOTTLE, PUMP
Product NDC 10812-173
Product Type Name HUMAN OTC DRUG
Non Proprietary Name Avobenzone, Homosalate, Octisalate, Octocrylene, and Oxybenzone
Dosage Form Name CREAM
Route Name TOPICAL
Start Marketing Date 20100415
Marketing Category Name OTC MONOGRAPH FINAL
Labeler Name Neutrogena Corporation
Substance Name AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE; OXYBENZONE
Strength Number 30; 120; 50; 50; 30
Strength Unit mg/mL; mg/mL; mg/mL; mg/mL; mg/mL
Pharmaceutical Classes

Complete Information of Neutrogena Clinical Lifting Wrinkle Treatment System


General Information